Why do specialty drugmakers shell out on DTC? A few hits can pay off

Direct-to-consumer advertising may not seem like the most logical investment for companies trying to reach tiny, targeted patient populations. When drug prices are high enough, though? It's worth it for some drugmakers, and that's got them putting some of the industry's priciest treatments on display. More from FiercePharma